The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.

The U.S. Food and Drug Administration (FDA) is changing the game on COVID-19 vaccines. Instead of approving yearly boosters ...

US Food and Drug Administration officials are changing the agency's standards for updated COVID-19 booster shots with focus ...

The FDA also requested Novavax conduct a phase 4 study in patients aged 50 to 64 years without high-risk conditions for severe COVID-19.

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's ...

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.